chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Haemodialysis, Haemoglobin decreased, Hyperkalaemia, Hypotension, Hypoxia
Clinical narrative: Patient is a 76 y.o. male patient of MD with history of ESRD, CAD, T2DM, HLD, HLD who presented with seizure like activity found to have COVID. Hospitalization complicated by COPD exacerbation, Acute respiratory failure   Acute Respiratory Failure w/Hypoxia Acute Exacerbation of COPD Likely secondary to ongoing smoking Requiring 2-4L NC on admission, no baseline recs Initial CT w/o acute pathology,  emphysema Start scheduled/PRN Nebs, PO steroids Aggressive pulmonary hygiene Wean O2 as able to maintain SpO2 88-92% On 2L NC-stable 11/25 Home O2 eval prior to DC-qualified Cont pulse ox   Covid-19 Virus Infection Date of onset of symptoms: 11/20 Symptoms present on admission: 11/20 Date of covid positive test: 11/20 Vaccination status: vaccinated Imaging: CXR reviewed by me without obvious pneumonia CT Chest-No acute process within the lungs.Moderate COPD. Scattered areas of pleural thickening and calcification likely related to prior asbestos exposure.Aortic endograft.Mild cholelithiasis. Oxygen requirements on admission: 3L Current oxygen requirements: 2L NC Medical therapy: remdesivir and steroids Consultants following: Nephrology Anticipated special isolation end date: 12/1 CRP 47.5, Ferritin 802, LDH 225 Follow Seizure-like activity Unclear etiology Noted during iHD Denies h/o sz but + h/o TBI No focal neuro deficits on exam Initial LA elevated CTH Brain-No acute intracranial abnormality. Neurology consulted-We will attempt to obtain a routine EEG.  If we are unable to obtain it today as he is receiving dialysis, it can be obtained as an outpatient.  No antiepileptic medication is recommended at this time.  Seizure precautions   Anemia in ESRD Thrombocytopenia-Resolved Baseline Hb 10-11   Hb 8.7  11/21 and 11/22, 8 11/24, 7.3  11/26 Baseline Plts normal  Plts 132 11/21 and 131  11/22, 142  11/24 Likely secondary to underlying renal dyfxn No e/o bleeding on exam Follow per PCP   Hyperkalemia-Resolved ESRD Potassium 5.4  11/22; 11/23 HD MWF  access RIJ PC-changing due to covid infection to  TTS starting Saturday and can return to original unit 12/1 Primary Nephrologist: consulted Limit nephrotoxins as able   T2DM, non-insulin dependent DM Peripheral Neuropathy Chronic, diet controlled BG 135, A1c 4.7 (2021) repeat 4.7 on 11/20/23 NARx check 11/22 continue home gabapentin   Tobacco Use Disorder Smokes 1 PPD >3 minutes spent counseling cessation Declined NRT while hospitalized CAD s/p MI s/p pacer HLD AAA Cont Statin Not on ASA Holding Toprol due to low Bp Resume per renal dosing at DC with Imdur(plans to take post HD on HD days if w/in parameters) Needs outpt f/u ASAP with Cardiology as has missed some appt.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Platelet count decreased, Pleural thickening, Pulmonary calcification, Renal impairment, SARS-CoV-2 test positive
Clinical narrative: Patient is a 76 y.o. male patient of MD with history of ESRD, CAD, T2DM, HLD, HLD who presented with seizure like activity found to have COVID. Hospitalization complicated by COPD exacerbation, Acute respiratory failure   Acute Respiratory Failure w/Hypoxia Acute Exacerbation of COPD Likely secondary to ongoing smoking Requiring 2-4L NC on admission, no baseline recs Initial CT w/o acute pathology,  emphysema Start scheduled/PRN Nebs, PO steroids Aggressive pulmonary hygiene Wean O2 as able to maintain SpO2 88-92% On 2L NC-stable 11/25 Home O2 eval prior to DC-qualified Cont pulse ox   Covid-19 Virus Infection Date of onset of symptoms: 11/20 Symptoms present on admission: 11/20 Date of covid positive test: 11/20 Vaccination status: vaccinated Imaging: CXR reviewed by me without obvious pneumonia CT Chest-No acute process within the lungs.Moderate COPD. Scattered areas of pleural thickening and calcification likely related to prior asbestos exposure.Aortic endograft.Mild cholelithiasis. Oxygen requirements on admission: 3L Current oxygen requirements: 2L NC Medical therapy: remdesivir and steroids Consultants following: Nephrology Anticipated special isolation end date: 12/1 CRP 47.5, Ferritin 802, LDH 225 Follow Seizure-like activity Unclear etiology Noted during iHD Denies h/o sz but + h/o TBI No focal neuro deficits on exam Initial LA elevated CTH Brain-No acute intracranial abnormality. Neurology consulted-We will attempt to obtain a routine EEG.  If we are unable to obtain it today as he is receiving dialysis, it can be obtained as an outpatient.  No antiepileptic medication is recommended at this time.  Seizure precautions   Anemia in ESRD Thrombocytopenia-Resolved Baseline Hb 10-11   Hb 8.7  11/21 and 11/22, 8 11/24, 7.3  11/26 Baseline Plts normal  Plts 132 11/21 and 131  11/22, 142  11/24 Likely secondary to underlying renal dyfxn No e/o bleeding on exam Follow per PCP   Hyperkalemia-Resolved ESRD Potassium 5.4  11/22; 11/23 HD MWF  access RIJ PC-changing due to covid infection to  TTS starting Saturday and can return to original unit 12/1 Primary Nephrologist: consulted Limit nephrotoxins as able   T2DM, non-insulin dependent DM Peripheral Neuropathy Chronic, diet controlled BG 135, A1c 4.7 (2021) repeat 4.7 on 11/20/23 NARx check 11/22 continue home gabapentin   Tobacco Use Disorder Smokes 1 PPD >3 minutes spent counseling cessation Declined NRT while hospitalized CAD s/p MI s/p pacer HLD AAA Cont Statin Not on ASA Holding Toprol due to low Bp Resume per renal dosing at DC with Imdur(plans to take post HD on HD days if w/in parameters) Needs outpt f/u ASAP with Cardiology as has missed some appt.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Seizure like phenomena, Serum ferritin increased, Thrombocytopenia
Clinical narrative: Patient is a 76 y.o. male patient of MD with history of ESRD, CAD, T2DM, HLD, HLD who presented with seizure like activity found to have COVID. Hospitalization complicated by COPD exacerbation, Acute respiratory failure   Acute Respiratory Failure w/Hypoxia Acute Exacerbation of COPD Likely secondary to ongoing smoking Requiring 2-4L NC on admission, no baseline recs Initial CT w/o acute pathology,  emphysema Start scheduled/PRN Nebs, PO steroids Aggressive pulmonary hygiene Wean O2 as able to maintain SpO2 88-92% On 2L NC-stable 11/25 Home O2 eval prior to DC-qualified Cont pulse ox   Covid-19 Virus Infection Date of onset of symptoms: 11/20 Symptoms present on admission: 11/20 Date of covid positive test: 11/20 Vaccination status: vaccinated Imaging: CXR reviewed by me without obvious pneumonia CT Chest-No acute process within the lungs.Moderate COPD. Scattered areas of pleural thickening and calcification likely related to prior asbestos exposure.Aortic endograft.Mild cholelithiasis. Oxygen requirements on admission: 3L Current oxygen requirements: 2L NC Medical therapy: remdesivir and steroids Consultants following: Nephrology Anticipated special isolation end date: 12/1 CRP 47.5, Ferritin 802, LDH 225 Follow Seizure-like activity Unclear etiology Noted during iHD Denies h/o sz but + h/o TBI No focal neuro deficits on exam Initial LA elevated CTH Brain-No acute intracranial abnormality. Neurology consulted-We will attempt to obtain a routine EEG.  If we are unable to obtain it today as he is receiving dialysis, it can be obtained as an outpatient.  No antiepileptic medication is recommended at this time.  Seizure precautions   Anemia in ESRD Thrombocytopenia-Resolved Baseline Hb 10-11   Hb 8.7  11/21 and 11/22, 8 11/24, 7.3  11/26 Baseline Plts normal  Plts 132 11/21 and 131  11/22, 142  11/24 Likely secondary to underlying renal dyfxn No e/o bleeding on exam Follow per PCP   Hyperkalemia-Resolved ESRD Potassium 5.4  11/22; 11/23 HD MWF  access RIJ PC-changing due to covid infection to  TTS starting Saturday and can return to original unit 12/1 Primary Nephrologist: consulted Limit nephrotoxins as able   T2DM, non-insulin dependent DM Peripheral Neuropathy Chronic, diet controlled BG 135, A1c 4.7 (2021) repeat 4.7 on 11/20/23 NARx check 11/22 continue home gabapentin   Tobacco Use Disorder Smokes 1 PPD >3 minutes spent counseling cessation Declined NRT while hospitalized CAD s/p MI s/p pacer HLD AAA Cont Statin Not on ASA Holding Toprol due to low Bp Resume per renal dosing at DC with Imdur(plans to take post HD on HD days if w/in parameters) Needs outpt f/u ASAP with Cardiology as has missed some appt.
Age: 45.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Pain, Pruritus, Urticaria
Clinical narrative: 12 days after the booster shot, I started developing painful and itchy hives. I was prescribed a 15 day course of Prednisone 10 mg (4 tabs x 5 days, 2 tabs x 5, 1 tab x 5 days). I've also been taking 4 Benedryl per day, 1 Zyrtec per day, and occasional famotidine 20 mg. The hives are still present and still itchy after 10 days of treatment.  The reason I believe this is caused by the vaccine is because two years ago the exact same thing happened to me after receiving the Moderna booster. However, at the time doctors attributed the hives to an antibiotic. At that time, I had developed an infection at the injection site and was put on a strong antibiotic. 11 days after receiving that shot, I broke out in hives. In the same manner, I was prescribed a steriod to deal with the hives. They were very present for about a month and then occasionally for up to six months afterward.
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse events occured
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Atrial fibrillation, Atrial pressure increased, Blood magnesium normal, Blood potassium decreased
Clinical narrative: Patient is a 78 y.o. female patient of MD with history of  history of CAD, HFFpEF,  Atrial Fibrillation on coumadin, hypertension, hyperlipidemia, type 2 diabetes mellitus, ESRD in HD MWF schedule, chronic anemia  presented to  Hospital with worsening shortness of breath with hypoxia associated with dry cough, chills, generalized body ache. Reports she could not able finish dialysis due to  worsening shortness of breath.    Acute hypoxemic resp failure - Resolved COVID-19 infection Volume overload 2/2 ESRD with partial HD session HFpEF, mild decompensation P/w worsening shortness of breath associated with dry cough, chills, generalized body ache.  Required 2L NC on admission, baseline room air  Afebrile, no leukocytosis, HDS  CXR no pneumothorax, pleural effusion or focal airspace consolidation.  Started on oral decadron 6 mg for 10 days Volume mgmt via HD Albuterol inhaler, mucinex scheduled, PRN robitussin-DM Pulm toilet  Now stable on RA   Hypokalemia K 3.2, Mg wnl  Likely 2.2 poor PO intake  Hold off on PO replacement given ESRD on HD Recommend repeat BMP in 1 week    Elevated troponin Chronic HFpEF A Fib S/p  WATCHMAN device   Denied chest pain  Troponin elevated but adynamic, likely type II in setting of ESRD EKG no acute ischemic changes noted CXR Non acute  S/p successful placement of WATCHMAN device 11/17/23 2/2023 ECHO with LVEF>70%, G2DD with elevated LAP. Mild pulmonary HTN; RVSP 55  Continue home aspirin and coreg pharmacy to dose coumadin Hypertension Continue home amlodipine, coreg and hydralazine   ESRD on HD MWF  Anemia of chronic kidney disease Consult nephrology for maintenance HD.  Stable hemoglobin 8.4 (baseline 8-10) No active bleeding noted  Monitor Labs    T2DM Well controlled A1c 4.7 Patient reports common AM hypoglycemic episodes Decreased home lantus SSI, DM diet  Recommend BG log and follow up with PCP
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cardiac failure, Chest X-ray normal, Chills, Condition aggravated
Clinical narrative: Patient is a 78 y.o. female patient of MD with history of  history of CAD, HFFpEF,  Atrial Fibrillation on coumadin, hypertension, hyperlipidemia, type 2 diabetes mellitus, ESRD in HD MWF schedule, chronic anemia  presented to  Hospital with worsening shortness of breath with hypoxia associated with dry cough, chills, generalized body ache. Reports she could not able finish dialysis due to  worsening shortness of breath.    Acute hypoxemic resp failure - Resolved COVID-19 infection Volume overload 2/2 ESRD with partial HD session HFpEF, mild decompensation P/w worsening shortness of breath associated with dry cough, chills, generalized body ache.  Required 2L NC on admission, baseline room air  Afebrile, no leukocytosis, HDS  CXR no pneumothorax, pleural effusion or focal airspace consolidation.  Started on oral decadron 6 mg for 10 days Volume mgmt via HD Albuterol inhaler, mucinex scheduled, PRN robitussin-DM Pulm toilet  Now stable on RA   Hypokalemia K 3.2, Mg wnl  Likely 2.2 poor PO intake  Hold off on PO replacement given ESRD on HD Recommend repeat BMP in 1 week    Elevated troponin Chronic HFpEF A Fib S/p  WATCHMAN device   Denied chest pain  Troponin elevated but adynamic, likely type II in setting of ESRD EKG no acute ischemic changes noted CXR Non acute  S/p successful placement of WATCHMAN device 11/17/23 2/2023 ECHO with LVEF>70%, G2DD with elevated LAP. Mild pulmonary HTN; RVSP 55  Continue home aspirin and coreg pharmacy to dose coumadin Hypertension Continue home amlodipine, coreg and hydralazine   ESRD on HD MWF  Anemia of chronic kidney disease Consult nephrology for maintenance HD.  Stable hemoglobin 8.4 (baseline 8-10) No active bleeding noted  Monitor Labs    T2DM Well controlled A1c 4.7 Patient reports common AM hypoglycemic episodes Decreased home lantus SSI, DM diet  Recommend BG log and follow up with PCP
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Diastolic dysfunction, Dyspnoea, Echocardiogram abnormal, Ejection fraction
Clinical narrative: Patient is a 78 y.o. female patient of MD with history of  history of CAD, HFFpEF,  Atrial Fibrillation on coumadin, hypertension, hyperlipidemia, type 2 diabetes mellitus, ESRD in HD MWF schedule, chronic anemia  presented to  Hospital with worsening shortness of breath with hypoxia associated with dry cough, chills, generalized body ache. Reports she could not able finish dialysis due to  worsening shortness of breath.    Acute hypoxemic resp failure - Resolved COVID-19 infection Volume overload 2/2 ESRD with partial HD session HFpEF, mild decompensation P/w worsening shortness of breath associated with dry cough, chills, generalized body ache.  Required 2L NC on admission, baseline room air  Afebrile, no leukocytosis, HDS  CXR no pneumothorax, pleural effusion or focal airspace consolidation.  Started on oral decadron 6 mg for 10 days Volume mgmt via HD Albuterol inhaler, mucinex scheduled, PRN robitussin-DM Pulm toilet  Now stable on RA   Hypokalemia K 3.2, Mg wnl  Likely 2.2 poor PO intake  Hold off on PO replacement given ESRD on HD Recommend repeat BMP in 1 week    Elevated troponin Chronic HFpEF A Fib S/p  WATCHMAN device   Denied chest pain  Troponin elevated but adynamic, likely type II in setting of ESRD EKG no acute ischemic changes noted CXR Non acute  S/p successful placement of WATCHMAN device 11/17/23 2/2023 ECHO with LVEF>70%, G2DD with elevated LAP. Mild pulmonary HTN; RVSP 55  Continue home aspirin and coreg pharmacy to dose coumadin Hypertension Continue home amlodipine, coreg and hydralazine   ESRD on HD MWF  Anemia of chronic kidney disease Consult nephrology for maintenance HD.  Stable hemoglobin 8.4 (baseline 8-10) No active bleeding noted  Monitor Labs    T2DM Well controlled A1c 4.7 Patient reports common AM hypoglycemic episodes Decreased home lantus SSI, DM diet  Recommend BG log and follow up with PCP
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Electrocardiogram normal, End stage renal disease, Glycosylated haemoglobin normal, Haemodialysis, Haemoglobin decreased
Clinical narrative: Patient is a 78 y.o. female patient of MD with history of  history of CAD, HFFpEF,  Atrial Fibrillation on coumadin, hypertension, hyperlipidemia, type 2 diabetes mellitus, ESRD in HD MWF schedule, chronic anemia  presented to  Hospital with worsening shortness of breath with hypoxia associated with dry cough, chills, generalized body ache. Reports she could not able finish dialysis due to  worsening shortness of breath.    Acute hypoxemic resp failure - Resolved COVID-19 infection Volume overload 2/2 ESRD with partial HD session HFpEF, mild decompensation P/w worsening shortness of breath associated with dry cough, chills, generalized body ache.  Required 2L NC on admission, baseline room air  Afebrile, no leukocytosis, HDS  CXR no pneumothorax, pleural effusion or focal airspace consolidation.  Started on oral decadron 6 mg for 10 days Volume mgmt via HD Albuterol inhaler, mucinex scheduled, PRN robitussin-DM Pulm toilet  Now stable on RA   Hypokalemia K 3.2, Mg wnl  Likely 2.2 poor PO intake  Hold off on PO replacement given ESRD on HD Recommend repeat BMP in 1 week    Elevated troponin Chronic HFpEF A Fib S/p  WATCHMAN device   Denied chest pain  Troponin elevated but adynamic, likely type II in setting of ESRD EKG no acute ischemic changes noted CXR Non acute  S/p successful placement of WATCHMAN device 11/17/23 2/2023 ECHO with LVEF>70%, G2DD with elevated LAP. Mild pulmonary HTN; RVSP 55  Continue home aspirin and coreg pharmacy to dose coumadin Hypertension Continue home amlodipine, coreg and hydralazine   ESRD on HD MWF  Anemia of chronic kidney disease Consult nephrology for maintenance HD.  Stable hemoglobin 8.4 (baseline 8-10) No active bleeding noted  Monitor Labs    T2DM Well controlled A1c 4.7 Patient reports common AM hypoglycemic episodes Decreased home lantus SSI, DM diet  Recommend BG log and follow up with PCP
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypervolaemia, Hypokalaemia, Hypophagia, Hypoxia, Left atrial appendage closure implant
Clinical narrative: Patient is a 78 y.o. female patient of MD with history of  history of CAD, HFFpEF,  Atrial Fibrillation on coumadin, hypertension, hyperlipidemia, type 2 diabetes mellitus, ESRD in HD MWF schedule, chronic anemia  presented to  Hospital with worsening shortness of breath with hypoxia associated with dry cough, chills, generalized body ache. Reports she could not able finish dialysis due to  worsening shortness of breath.    Acute hypoxemic resp failure - Resolved COVID-19 infection Volume overload 2/2 ESRD with partial HD session HFpEF, mild decompensation P/w worsening shortness of breath associated with dry cough, chills, generalized body ache.  Required 2L NC on admission, baseline room air  Afebrile, no leukocytosis, HDS  CXR no pneumothorax, pleural effusion or focal airspace consolidation.  Started on oral decadron 6 mg for 10 days Volume mgmt via HD Albuterol inhaler, mucinex scheduled, PRN robitussin-DM Pulm toilet  Now stable on RA   Hypokalemia K 3.2, Mg wnl  Likely 2.2 poor PO intake  Hold off on PO replacement given ESRD on HD Recommend repeat BMP in 1 week    Elevated troponin Chronic HFpEF A Fib S/p  WATCHMAN device   Denied chest pain  Troponin elevated but adynamic, likely type II in setting of ESRD EKG no acute ischemic changes noted CXR Non acute  S/p successful placement of WATCHMAN device 11/17/23 2/2023 ECHO with LVEF>70%, G2DD with elevated LAP. Mild pulmonary HTN; RVSP 55  Continue home aspirin and coreg pharmacy to dose coumadin Hypertension Continue home amlodipine, coreg and hydralazine   ESRD on HD MWF  Anemia of chronic kidney disease Consult nephrology for maintenance HD.  Stable hemoglobin 8.4 (baseline 8-10) No active bleeding noted  Monitor Labs    T2DM Well controlled A1c 4.7 Patient reports common AM hypoglycemic episodes Decreased home lantus SSI, DM diet  Recommend BG log and follow up with PCP
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Left ventricular failure, Pain, Troponin increased
Clinical narrative: Patient is a 78 y.o. female patient of MD with history of  history of CAD, HFFpEF,  Atrial Fibrillation on coumadin, hypertension, hyperlipidemia, type 2 diabetes mellitus, ESRD in HD MWF schedule, chronic anemia  presented to  Hospital with worsening shortness of breath with hypoxia associated with dry cough, chills, generalized body ache. Reports she could not able finish dialysis due to  worsening shortness of breath.    Acute hypoxemic resp failure - Resolved COVID-19 infection Volume overload 2/2 ESRD with partial HD session HFpEF, mild decompensation P/w worsening shortness of breath associated with dry cough, chills, generalized body ache.  Required 2L NC on admission, baseline room air  Afebrile, no leukocytosis, HDS  CXR no pneumothorax, pleural effusion or focal airspace consolidation.  Started on oral decadron 6 mg for 10 days Volume mgmt via HD Albuterol inhaler, mucinex scheduled, PRN robitussin-DM Pulm toilet  Now stable on RA   Hypokalemia K 3.2, Mg wnl  Likely 2.2 poor PO intake  Hold off on PO replacement given ESRD on HD Recommend repeat BMP in 1 week    Elevated troponin Chronic HFpEF A Fib S/p  WATCHMAN device   Denied chest pain  Troponin elevated but adynamic, likely type II in setting of ESRD EKG no acute ischemic changes noted CXR Non acute  S/p successful placement of WATCHMAN device 11/17/23 2/2023 ECHO with LVEF>70%, G2DD with elevated LAP. Mild pulmonary HTN; RVSP 55  Continue home aspirin and coreg pharmacy to dose coumadin Hypertension Continue home amlodipine, coreg and hydralazine   ESRD on HD MWF  Anemia of chronic kidney disease Consult nephrology for maintenance HD.  Stable hemoglobin 8.4 (baseline 8-10) No active bleeding noted  Monitor Labs    T2DM Well controlled A1c 4.7 Patient reports common AM hypoglycemic episodes Decreased home lantus SSI, DM diet  Recommend BG log and follow up with PCP
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse events occured
Age: 1.67
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse events occured
Age: 1.83
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 1.33
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 0.5
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 1.17
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: The patient received the Spikevax vaccine on 12/28/23.   She called the pharmacy on 12/29/23 and stated that her arm was very sore and she is currently unable to move it.  She was concerned about it possibly could have been administered too high.  She plans to follow up with her certified nurse practioner next week if she is still unable to move her arm.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 1.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 0.83
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Nausea, Syncope
Clinical narrative: Patient received Pfizer Comirnaty 23-34 Vaccine at approximately 1:17PM 12/29/23 and returned to waiting area where he asked for help as he wasn't feeling well "and might vomit." Staff called 911 at 1:20PM. Fire Dept and EMS/Ambulance arrived at 1:22PM to assess the patient. Patient experienced several "fainting" episodes. I assessed patient as having syncope episode and took patient's Blood Pressure + Pulse (112/71, 71bpm) before EMS arrived. EMS cleared the patient safe to leave about 2:20PM. Patient revealed that he has felt "woozy or vaso-vagal" after receiving vaccines in the past, "but never like this"; but has also had several changes to hypertension drugs in the past month.
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 0.75
Sex: F
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: Patient received correct COVID vaccine for age, manufacturer expiration date was not expired, but date added by pharmacy as "best use by date" was expired on 12/18/2023.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 1.5
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 0.92
Sex: M
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: Patient received correct COVID vaccine for age, manufacturer expiration date was not expired, but date added by pharmacy as "best use by date" was expired on 12/18/2023.
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache
Clinical narrative: Before having the vaccine, the synptoms of having cold  are just  running nose and cough.  Now, after I get the vaccine, I have serious headaches whenever I get cold. The running nose and cough symptoms are gone or become very minor.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 0.5
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 1.5
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 68.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Unevaluable event
Clinical narrative: Vaccine Refridgerated
Age: 7.0
Sex: M
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: Patient received correct COVID vaccine for age, manufacturer expiration date was not expired, but date added by pharmacy as "best use by date" was expired on 12/18/2023.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions
Age: 10.0
Sex: M
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: Patient received correct COVID vaccine for age, manufacturer expiration date was not expired, but date added by pharmacy as "best use by date" was expired on 12/18/2023.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Back pain, Burning sensation, Erythema, Herpes zoster
Clinical narrative: Day after receiving vaccine felt burning and itching sensation on left arm and torso with no indication of rash. I thought maybe I was bitten by an insect. 2nd day itching still there and now red/pink patches appeared. as days continued it got worse and also had stomach cramps and dull back pain around day 2 or 3. Read information on side effects of vaccine and thought maybe it would go away in 3 days or so, but it did not. Went back to pharmacy where received vaccine and talked to pharmacist. she said I probably had a reacction to vaccine and offered a few over the counter products to alleviate itch. said she had no other reported issues with the vaccine like this and would report it and took my name. That night th itching became worse and had back pain. On December 28th, I called dermatologist but could not get appt. so went to Urgent care. I was diagnosed with Shingles and Doctor prescribed anti viral and steroids.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Rash
Clinical narrative: Day after receiving vaccine felt burning and itching sensation on left arm and torso with no indication of rash. I thought maybe I was bitten by an insect. 2nd day itching still there and now red/pink patches appeared. as days continued it got worse and also had stomach cramps and dull back pain around day 2 or 3. Read information on side effects of vaccine and thought maybe it would go away in 3 days or so, but it did not. Went back to pharmacy where received vaccine and talked to pharmacist. she said I probably had a reacction to vaccine and offered a few over the counter products to alleviate itch. said she had no other reported issues with the vaccine like this and would report it and took my name. That night th itching became worse and had back pain. On December 28th, I called dermatologist but could not get appt. so went to Urgent care. I was diagnosed with Shingles and Doctor prescribed anti viral and steroids.
Age: 3.0
Sex: F
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: Patient received correct COVID vaccine for age, manufacturer expiration date was not expired, but date added by pharmacy as "best use by date" was expired on 12/18/2023.
Age: 60.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Unevaluable event
Clinical narrative: Vaccine Refridgerated
Age: 4.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Patient received correct COVID vaccine for age, manufacturer expiration date was not expired, but date added by pharmacy as "best use by date" was expired on 12/18/2023.
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: None stated
Age: 10.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Patient received correct COVID vaccine for age, manufacturer expiration date was not expired, but date added by pharmacy as "best use by date" was expired on 12/18/2023.
Age: 61.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 1.25
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Patient received correct COVID vaccine for age, manufacturer expiration date was not expired, but date added by pharmacy as "best use by date" was expired on 12/18/2023.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory distress syndrome, Acute respiratory failure, Anaemia, Azotaemia, Blood creatinine normal
Clinical narrative: Patient is a 62 y.o. male, nursing home resident with history of end-stage COPD on 4L NC at home, hypertension, hyperlipidemia, CHF, alcohol abuse, diabetes mellitus type 2, who presented to Country Hospital with respiratory distress and hypoxia then transferred to General Hospital.    Goal of care Palliative following, pt with very poor prognosis, advanced COPD on Vent due to COVID with multiple complications.  Discussed with family and code status changed to DNR CC, compassion extubation done 11/22. Pt to be admitted to inpt hospice.  Comfort medication ordered.    Acute on chronic hypoxic hypercapnic respiratory failure Acute COPD exacerbation COVID 19 with ARDS MRSA cavitary pneumonia Possibly COPD exacerbation precipitated by COVID infection. Patient oxygen home requirement on 4 L nasal cannula. Required BIPAP and later intubated at County before transferring to on 11/13. Sputum culture 11/14 + MRSA Antibiotics changed from Rocephin and azithromycin to vancomycin. Cefepime clinda started on 11/20 for arm cellulitis Received remdesevir and dexamethasone.   CT chest repeated today (11/20) Multiple cavitating lesions in the right lung, probable cavitating pneumonia Pulmonary following   Off pressors since 11/16 Compassion extubation 11/22/23   Left upper extremity cellulitis Noted worsening erythema and edema of LUE 11/20. CT arm  Multiple foci of air density are identified within the soft tissues along the medial aspect of the left upper arm,  findings suspicious for necrotizing infection with a gas-forming organism/necrotizing fasciitis Surgery took pt to OR, no clear signs of Nec fasc, I&D done 11/20. Wound cultures negative  Received  Cefepime, clinda, Vancomycin Wound care   Thrombocytopenia Chronic anemia Platelets remains low at 122k, no signs of bleeding. Hb stable ~11 Due to acute illness monitor   Uremia Ongoing uremia, BUN improving 58. normal Cr I/O overall even, but -1.5L in the last 24 hrs. Monitor for now   HFpEF, chronic Hypertension EKG showed sinus tachycardia with no acute ischemic changes. Initial hypotension requiring pressors, now resolved.  Metoprolol initiated 11/17 Diabetes mellitus type 2 complicated with peripheral neuropathy Blood glucose 120, and last A1c 14%. HA1C 7.4. Continue Lantus and Monitor blood glucose and start SSI during admission. Continue home gabapentin.   Alcoholic liver cirrhosis with Ascites History of alcohol abuse hold home lasix and spironolactone.   schizoaffective disorder Bipolar disorder History of seizure Continue home Abilify, and Keppra.   Morbid obesity BMI 32.77 kg/M2. Lifestyle modification is recommended.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Blood urea increased, COVID-19, Cellulitis, Chronic obstructive pulmonary disease
Clinical narrative: Patient is a 62 y.o. male, nursing home resident with history of end-stage COPD on 4L NC at home, hypertension, hyperlipidemia, CHF, alcohol abuse, diabetes mellitus type 2, who presented to Country Hospital with respiratory distress and hypoxia then transferred to General Hospital.    Goal of care Palliative following, pt with very poor prognosis, advanced COPD on Vent due to COVID with multiple complications.  Discussed with family and code status changed to DNR CC, compassion extubation done 11/22. Pt to be admitted to inpt hospice.  Comfort medication ordered.    Acute on chronic hypoxic hypercapnic respiratory failure Acute COPD exacerbation COVID 19 with ARDS MRSA cavitary pneumonia Possibly COPD exacerbation precipitated by COVID infection. Patient oxygen home requirement on 4 L nasal cannula. Required BIPAP and later intubated at County before transferring to on 11/13. Sputum culture 11/14 + MRSA Antibiotics changed from Rocephin and azithromycin to vancomycin. Cefepime clinda started on 11/20 for arm cellulitis Received remdesevir and dexamethasone.   CT chest repeated today (11/20) Multiple cavitating lesions in the right lung, probable cavitating pneumonia Pulmonary following   Off pressors since 11/16 Compassion extubation 11/22/23   Left upper extremity cellulitis Noted worsening erythema and edema of LUE 11/20. CT arm  Multiple foci of air density are identified within the soft tissues along the medial aspect of the left upper arm,  findings suspicious for necrotizing infection with a gas-forming organism/necrotizing fasciitis Surgery took pt to OR, no clear signs of Nec fasc, I&D done 11/20. Wound cultures negative  Received  Cefepime, clinda, Vancomycin Wound care   Thrombocytopenia Chronic anemia Platelets remains low at 122k, no signs of bleeding. Hb stable ~11 Due to acute illness monitor   Uremia Ongoing uremia, BUN improving 58. normal Cr I/O overall even, but -1.5L in the last 24 hrs. Monitor for now   HFpEF, chronic Hypertension EKG showed sinus tachycardia with no acute ischemic changes. Initial hypotension requiring pressors, now resolved.  Metoprolol initiated 11/17 Diabetes mellitus type 2 complicated with peripheral neuropathy Blood glucose 120, and last A1c 14%. HA1C 7.4. Continue Lantus and Monitor blood glucose and start SSI during admission. Continue home gabapentin.   Alcoholic liver cirrhosis with Ascites History of alcohol abuse hold home lasix and spironolactone.   schizoaffective disorder Bipolar disorder History of seizure Continue home Abilify, and Keppra.   Morbid obesity BMI 32.77 kg/M2. Lifestyle modification is recommended.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram abnormal, Computerised tomogram limb, Computerised tomogram thorax abnormal, Condition aggravated, Culture wound negative
Clinical narrative: Patient is a 62 y.o. male, nursing home resident with history of end-stage COPD on 4L NC at home, hypertension, hyperlipidemia, CHF, alcohol abuse, diabetes mellitus type 2, who presented to Country Hospital with respiratory distress and hypoxia then transferred to General Hospital.    Goal of care Palliative following, pt with very poor prognosis, advanced COPD on Vent due to COVID with multiple complications.  Discussed with family and code status changed to DNR CC, compassion extubation done 11/22. Pt to be admitted to inpt hospice.  Comfort medication ordered.    Acute on chronic hypoxic hypercapnic respiratory failure Acute COPD exacerbation COVID 19 with ARDS MRSA cavitary pneumonia Possibly COPD exacerbation precipitated by COVID infection. Patient oxygen home requirement on 4 L nasal cannula. Required BIPAP and later intubated at County before transferring to on 11/13. Sputum culture 11/14 + MRSA Antibiotics changed from Rocephin and azithromycin to vancomycin. Cefepime clinda started on 11/20 for arm cellulitis Received remdesevir and dexamethasone.   CT chest repeated today (11/20) Multiple cavitating lesions in the right lung, probable cavitating pneumonia Pulmonary following   Off pressors since 11/16 Compassion extubation 11/22/23   Left upper extremity cellulitis Noted worsening erythema and edema of LUE 11/20. CT arm  Multiple foci of air density are identified within the soft tissues along the medial aspect of the left upper arm,  findings suspicious for necrotizing infection with a gas-forming organism/necrotizing fasciitis Surgery took pt to OR, no clear signs of Nec fasc, I&D done 11/20. Wound cultures negative  Received  Cefepime, clinda, Vancomycin Wound care   Thrombocytopenia Chronic anemia Platelets remains low at 122k, no signs of bleeding. Hb stable ~11 Due to acute illness monitor   Uremia Ongoing uremia, BUN improving 58. normal Cr I/O overall even, but -1.5L in the last 24 hrs. Monitor for now   HFpEF, chronic Hypertension EKG showed sinus tachycardia with no acute ischemic changes. Initial hypotension requiring pressors, now resolved.  Metoprolol initiated 11/17 Diabetes mellitus type 2 complicated with peripheral neuropathy Blood glucose 120, and last A1c 14%. HA1C 7.4. Continue Lantus and Monitor blood glucose and start SSI during admission. Continue home gabapentin.   Alcoholic liver cirrhosis with Ascites History of alcohol abuse hold home lasix and spironolactone.   schizoaffective disorder Bipolar disorder History of seizure Continue home Abilify, and Keppra.   Morbid obesity BMI 32.77 kg/M2. Lifestyle modification is recommended.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Disease complication, Electrocardiogram abnormal, Endotracheal intubation, Erythema, Glycosylated haemoglobin increased
Clinical narrative: Patient is a 62 y.o. male, nursing home resident with history of end-stage COPD on 4L NC at home, hypertension, hyperlipidemia, CHF, alcohol abuse, diabetes mellitus type 2, who presented to Country Hospital with respiratory distress and hypoxia then transferred to General Hospital.    Goal of care Palliative following, pt with very poor prognosis, advanced COPD on Vent due to COVID with multiple complications.  Discussed with family and code status changed to DNR CC, compassion extubation done 11/22. Pt to be admitted to inpt hospice.  Comfort medication ordered.    Acute on chronic hypoxic hypercapnic respiratory failure Acute COPD exacerbation COVID 19 with ARDS MRSA cavitary pneumonia Possibly COPD exacerbation precipitated by COVID infection. Patient oxygen home requirement on 4 L nasal cannula. Required BIPAP and later intubated at County before transferring to on 11/13. Sputum culture 11/14 + MRSA Antibiotics changed from Rocephin and azithromycin to vancomycin. Cefepime clinda started on 11/20 for arm cellulitis Received remdesevir and dexamethasone.   CT chest repeated today (11/20) Multiple cavitating lesions in the right lung, probable cavitating pneumonia Pulmonary following   Off pressors since 11/16 Compassion extubation 11/22/23   Left upper extremity cellulitis Noted worsening erythema and edema of LUE 11/20. CT arm  Multiple foci of air density are identified within the soft tissues along the medial aspect of the left upper arm,  findings suspicious for necrotizing infection with a gas-forming organism/necrotizing fasciitis Surgery took pt to OR, no clear signs of Nec fasc, I&D done 11/20. Wound cultures negative  Received  Cefepime, clinda, Vancomycin Wound care   Thrombocytopenia Chronic anemia Platelets remains low at 122k, no signs of bleeding. Hb stable ~11 Due to acute illness monitor   Uremia Ongoing uremia, BUN improving 58. normal Cr I/O overall even, but -1.5L in the last 24 hrs. Monitor for now   HFpEF, chronic Hypertension EKG showed sinus tachycardia with no acute ischemic changes. Initial hypotension requiring pressors, now resolved.  Metoprolol initiated 11/17 Diabetes mellitus type 2 complicated with peripheral neuropathy Blood glucose 120, and last A1c 14%. HA1C 7.4. Continue Lantus and Monitor blood glucose and start SSI during admission. Continue home gabapentin.   Alcoholic liver cirrhosis with Ascites History of alcohol abuse hold home lasix and spironolactone.   schizoaffective disorder Bipolar disorder History of seizure Continue home Abilify, and Keppra.   Morbid obesity BMI 32.77 kg/M2. Lifestyle modification is recommended.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Hypotension, Hypoxia, Illness, Incisional drainage
Clinical narrative: Patient is a 62 y.o. male, nursing home resident with history of end-stage COPD on 4L NC at home, hypertension, hyperlipidemia, CHF, alcohol abuse, diabetes mellitus type 2, who presented to Country Hospital with respiratory distress and hypoxia then transferred to General Hospital.    Goal of care Palliative following, pt with very poor prognosis, advanced COPD on Vent due to COVID with multiple complications.  Discussed with family and code status changed to DNR CC, compassion extubation done 11/22. Pt to be admitted to inpt hospice.  Comfort medication ordered.    Acute on chronic hypoxic hypercapnic respiratory failure Acute COPD exacerbation COVID 19 with ARDS MRSA cavitary pneumonia Possibly COPD exacerbation precipitated by COVID infection. Patient oxygen home requirement on 4 L nasal cannula. Required BIPAP and later intubated at County before transferring to on 11/13. Sputum culture 11/14 + MRSA Antibiotics changed from Rocephin and azithromycin to vancomycin. Cefepime clinda started on 11/20 for arm cellulitis Received remdesevir and dexamethasone.   CT chest repeated today (11/20) Multiple cavitating lesions in the right lung, probable cavitating pneumonia Pulmonary following   Off pressors since 11/16 Compassion extubation 11/22/23   Left upper extremity cellulitis Noted worsening erythema and edema of LUE 11/20. CT arm  Multiple foci of air density are identified within the soft tissues along the medial aspect of the left upper arm,  findings suspicious for necrotizing infection with a gas-forming organism/necrotizing fasciitis Surgery took pt to OR, no clear signs of Nec fasc, I&D done 11/20. Wound cultures negative  Received  Cefepime, clinda, Vancomycin Wound care   Thrombocytopenia Chronic anemia Platelets remains low at 122k, no signs of bleeding. Hb stable ~11 Due to acute illness monitor   Uremia Ongoing uremia, BUN improving 58. normal Cr I/O overall even, but -1.5L in the last 24 hrs. Monitor for now   HFpEF, chronic Hypertension EKG showed sinus tachycardia with no acute ischemic changes. Initial hypotension requiring pressors, now resolved.  Metoprolol initiated 11/17 Diabetes mellitus type 2 complicated with peripheral neuropathy Blood glucose 120, and last A1c 14%. HA1C 7.4. Continue Lantus and Monitor blood glucose and start SSI during admission. Continue home gabapentin.   Alcoholic liver cirrhosis with Ascites History of alcohol abuse hold home lasix and spironolactone.   schizoaffective disorder Bipolar disorder History of seizure Continue home Abilify, and Keppra.   Morbid obesity BMI 32.77 kg/M2. Lifestyle modification is recommended.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Mechanical ventilation, Necrotising soft tissue infection, Oedema peripheral, Platelet count decreased, Pneumonia necrotising
Clinical narrative: Patient is a 62 y.o. male, nursing home resident with history of end-stage COPD on 4L NC at home, hypertension, hyperlipidemia, CHF, alcohol abuse, diabetes mellitus type 2, who presented to Country Hospital with respiratory distress and hypoxia then transferred to General Hospital.    Goal of care Palliative following, pt with very poor prognosis, advanced COPD on Vent due to COVID with multiple complications.  Discussed with family and code status changed to DNR CC, compassion extubation done 11/22. Pt to be admitted to inpt hospice.  Comfort medication ordered.    Acute on chronic hypoxic hypercapnic respiratory failure Acute COPD exacerbation COVID 19 with ARDS MRSA cavitary pneumonia Possibly COPD exacerbation precipitated by COVID infection. Patient oxygen home requirement on 4 L nasal cannula. Required BIPAP and later intubated at County before transferring to on 11/13. Sputum culture 11/14 + MRSA Antibiotics changed from Rocephin and azithromycin to vancomycin. Cefepime clinda started on 11/20 for arm cellulitis Received remdesevir and dexamethasone.   CT chest repeated today (11/20) Multiple cavitating lesions in the right lung, probable cavitating pneumonia Pulmonary following   Off pressors since 11/16 Compassion extubation 11/22/23   Left upper extremity cellulitis Noted worsening erythema and edema of LUE 11/20. CT arm  Multiple foci of air density are identified within the soft tissues along the medial aspect of the left upper arm,  findings suspicious for necrotizing infection with a gas-forming organism/necrotizing fasciitis Surgery took pt to OR, no clear signs of Nec fasc, I&D done 11/20. Wound cultures negative  Received  Cefepime, clinda, Vancomycin Wound care   Thrombocytopenia Chronic anemia Platelets remains low at 122k, no signs of bleeding. Hb stable ~11 Due to acute illness monitor   Uremia Ongoing uremia, BUN improving 58. normal Cr I/O overall even, but -1.5L in the last 24 hrs. Monitor for now   HFpEF, chronic Hypertension EKG showed sinus tachycardia with no acute ischemic changes. Initial hypotension requiring pressors, now resolved.  Metoprolol initiated 11/17 Diabetes mellitus type 2 complicated with peripheral neuropathy Blood glucose 120, and last A1c 14%. HA1C 7.4. Continue Lantus and Monitor blood glucose and start SSI during admission. Continue home gabapentin.   Alcoholic liver cirrhosis with Ascites History of alcohol abuse hold home lasix and spironolactone.   schizoaffective disorder Bipolar disorder History of seizure Continue home Abilify, and Keppra.   Morbid obesity BMI 32.77 kg/M2. Lifestyle modification is recommended.